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Abstract
Background: The CD98 (4F2, FRP-1) is a widely expressed cell surface protein heterodimer
composed of a glycosylated heavy chain and a non-glycosylated light chain. Originally described as
a T cell activation antigen, it was later shown to function in amino acid transport, cell fusion and
homotypic cell aggregation. Several lines of evidence suggest its functional interaction with integrins
but the biochemical basis for this interaction has been unclear.
Results: We demonstrate that CD98 constitutively and specifically associates with β 1 integrins
(α 2β 1,α 3β 1, α 5β 1 and α 6β 1), but minimally with α 4β 1. Integrin-CD98 association was established
by reciprocal immunoprecipitation experiments, and confirmed by CD98-induced clustering of
α 3β 1 but not α 4β 1 on the surface of rhabdomyosarcoma cells. Integrin-CD98 association is
independent of the α  subunit cytoplasmic tail, is maintained in α 3β 1 ligand-interaction deficient
mutants, and is not inhibited by EDTA. Within the CD98 heavy chain, a C109S mutation (but not
a C330S mutation) caused a loss of β 1 integrin association. The same C109S mutation also caused
a loss of CD98 light chain association. Importantly, CD98 associated selectively with β 1 integrins
present in low density "light membrane" fractions on a sucrose gradient. CD98 was not present in
dense fractions that contained the majority of β 1 integrins. Notably, the C109S mutant of CD98,
that did not associate with β 1 integrins, showed also a reduced localization into light membrane
fractions.
Conclusions: We demonstrate that CD98 association with β 1 integrins is specific, occurs in the
context of low density membranes, and may require the CD98 light chain.
Background
The CD98 (4F2, FRP-1) molecule, a cell surface di-
sulfide-linked heterodimer, was originally described as a
T cell activation antigen [1], and later was shown to pro-
vide a co-stimulatory signal for CD3-mediated T-cell ac-
tivation [2], independent of CD28/CD80/CD86
interaction [3]. In other studies, triggering of human
monocyte CD98 could suppress T cell proliferation [4],
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or promote homotypic cell aggregation of monocytes [5].
Also, CD98 may be a target antigen for natural killer cells
[6], may mediate fusion of blood monocytes leading to
osteoclast formation [7,8], and may modulate hemat-
opoietic cell survival and differentiation [9].
The CD98 molecule is also widely expressed on rapidly
growing non-hematopoietic cells, where it may modulate
oncogenic transformation [10,11], metal ion transport
[12,13], cell fusion [14,15], and amino acid transport [16–
19]. CD98 is also expressed on normal proliferating tis-
sue such as the basal layer of squamous epithelia [20]
and on cells having secretion or transport functions [21].
Understanding of the role of CD98 in amino acid trans-
port has been greatly enhanced with the recent cloning
and characterization of multiple CD98 light chains. Dis-
tinct CD98 light chains appear to mediate distinct amino
acid transport activities (for review see [22,23]).
Several lines of evidence now suggest that CD98 may
modulate the functions of integrins. For example, CD98
and β 1 integrins may act together during T-cell co-stim-
ulation [24]. A genetic screen revealed that CD98 may
indirectly influence integrin affinity for ligand [25]. Also,
anti-CD98 mAb appeared to modulate integrin-depend-
ent adhesion in two separate studies [25,26]. In addition,
antibodies to both CD98 and α 3β 1 integrin promoted cell
fusion [27], and antibodies to β 1 and β 2 integrins
blocked monocyte cell-cell fusion and aggregation func-
tions induced by an anti-CD98 mAb [5]. Finally, like
CD98, the α 3β 1 integrin has been implicated in amino
acid transport [28].
The biochemical mechanism by which CD98 and in-
tegrins functionally interact remains unclear. The CD98
molecule associates specifically with immobilized β 1 in-
tegrin cytoplasmic tail fusion proteins under very mild
detergent conditions (0.05% Triton X-100) [29], but
CD98 has not yet been shown to interact physically with
intact  β 1 integrins. We began the present study by
searching for integrin-associated proteins in an unbiased
manner (i.e. we were not specifically looking for CD98).
We utilized a monoclonal antibody screening method in-
volving co-immunoprecipitation of integrins under non-
stringent detergent conditions [30,31]. Using this ap-
proach, we have previously discovered specific associa-
tions between particular β 1 integrins and other cell
surface molecules including CD147/EMMPRIN [31], and
various tetraspanin (transmembrane-4 superfamily)
proteins [30,32,33]. In this report we demonstrate for
the first time that CD98 constitutively and specifically
associates with intact β 1 integrin heterodimers. Specific
CD98-integrin interaction occurs in the context of low
density protein-lipid microdomains, possibly resembling
lipid rafts [34,35]. Several important signaling mole-
cules, including activated TCR, LAT and LCK are present
in organized raft-type microdomains, and integrity of
these microdomains is necessary for T cell receptor sig-
nal transduction [36,37]. Our present discovery that β 1
integrins specifically associate with CD98 in lipid micro-
domains helps to explain the functional connections be-
tween β 1 integrins and CD98 during T cell costimulation,
monocyte fusion, and elsewhere.
Results and Discussion
Identification of CD98 as a β 1 integrin-associated protein
Mice were immunized with MTSV1-7 human mammary
epithelial cells, and approximately 600 hybridomas were
generated. Upon monoclonal antibody screening, 16
were identified that co-immunoprecipitated integrins
without recognizing integrins directly. Of these, one rec-
ognized CD63 as reported previously [30], and three (in-
cluding mAb 6B12) recognized a disulfide-linked cell
surface heterodimer consisting of an 85 kD heavy chain
and a 35 kD light chain.
From I125 surface-labeled HT1080 cells, mAb 6B12 im-
munoprecipitated a heterodimer of 85 and 35 kD under
reducing conditions (Fig. 1, lane a, solid arrows) and a
single protein band of 120 kD under non-reducing condi-
tions (not shown) but no other protein bands when
lysates were prepared in 1% Triton XI 00 detergent.
However, in the less stringent Brij 58 detergent, mAb
6B12 co-immunoprecipitated an integrin-like protein
band of 130 kD (Fig. 1, lane b, dotted arrow). Similar re-
sults were noted when CHAPS or Brij 99 detergents were
used (not shown).
Because the proteins recognized by 6B12 resembled the
disulfide-linked 85 and 35 kD subunits of CD98 [38,39],
they were compared to authentic CD98 as precipitated
using mAb 4F2. Both mAb 4F2 and mAb 6B12 precipitat-
ed identical patterns of cell surface proteins, as seen by
reduced SDS-PAGE (Fig. 1A, lanes c,d). Furthermore,
preincubation of cell lysates with mAb 4F2 resulted in
loss of the antigen recognized by mAb 6B12 (not shown).
Upon addition of 10 mM DTT to cell lysates, mAb 6B12
immunoprecipitated only a 85 kD protein band, consist-
ent with specific recognition of the CD98 heavy chain.
Flow cytometry of CHO cells transfected with CD98
heavy chain cDNA confirmed that the CD98 heavy chain
is the 6B12 antigen (Fig. 1B). Also, by flow cytometry the
6B12 antigen was present at high levels on all human cell
lines tested (more than 20) as expected for CD98.
Specificity of CD98-integrin association
To identify the integrin-like 130 kD protein(s) co-precip-
itating with CD98, immune complexes prepared from
HT1080 cells were dissociated and reprecipitated with
mAb against various cell surface molecules. From CD98BMC Biochemistry 2001, 2:10  http://www.biomedcentral.com/1471-2091/2/10
immunoprecipitates we recovered α 3β 1 integrin, but not
other cell surface molecules, including the LDL receptor,
HLA class I, the metalloprotease regulator EMMPRIN
(CD 147), CD71, or CD 109 (Fig. 2A). Several other β 1 in-
tegrins that are abundant on HT1080 cells (α 3β 1, α 2β 1,
α 5β 1, and α 6β 1) also could be re-precipitated from CD98
immunoprecipitates (Fig. 2C). Using the same experi-
mental conditions, we were unable to detect α 4β 1 in
CD98 immunoprecitates prepared from the rhabdomy-
osarcoma cell line RD, the lymphoblastoid cell line
Molt4, or K562 cells transfected with α 4 integrin (not
shown). However, we did observe co-immunoprecipita-
tion of CD98 with α 4β 1 integrin in the presence of 2 mM
manganese (not shown). The precise role of manganese
is unclear. Incubation with anti-β 1 'activating antibody'
TS2/16 (not shown) did not mimic the effects of manga-
nese on α 4β 1-CD98 association. Thus, although manga-
nese is well known to "activate" β 1 integrins [60], this
activation may not be relevant to α 4β 1-CD98 associa-
tion. Comparison of material isolated from CD98 immu-
noprecipitates with total amounts of each integrin on the
cell surface indicates that approximately 5–10% of each
integrin is associated with CD98 (Fig. 2C, compare lanes
a-d with e-h). In a reciprocal experiment, CD98 heavy
chain was re-precipitated from an α 3β 1 integrin immu-
noprecipitate (Fig. 2B, lane a) at a level comparable to re-
precipitated CD81 (lane b), a molecule shown previously
to associate with α 3β 1 integrins [32]. Results in Fig. 2A
and 2B indicate that CD98-integrin complexes are dis-
tinct from previously described integrin-CD81 [32,40]
and integrin-CD147/EMMPRIN [31] complexes.
Because not all β 1 integrins associated constitutively
with CD98 (in the absence of manganese), the α  chain
must help regulate specificity of CD98 association. Nota-
bly, α 3 with a truncated cytoplasmic tail, and wild-type
α 3 associated equally well with CD98 (Fig. 2D, lanes c,d).
Thus, specificity for constitutive association with CD98
may reside in integrin α  chain extracellular or trans-
membrane domains. To check whether CD98 is a ligand
for α 3β 1 integrin, we used K562 cells transfected with
wild type α 3, or α 3 mutants deficient in adhesion to α 3
ligands laminin 5 (W220A) and invasin (Y218A) [41]. All
of these α 3 proteins constructs associated with CD98
(Fig. 2E). Notably, 2 mM EDTA had no inhibitory effect
on constitutive integrin-CD98 associations (not shown).
Thus, CD98 itself does not appear to be acting as an in-
tegrin ligand. We were unable to demonstrate any chang-
es in the adhesive functions of CHO cells upon CD98-
transfection. However, functional effects of transfected
human CD98 could be overshadowed by an excess of en-
dogenous hamster CD98.
Next we asked whether clustering of CD98 would induce
selective clustering of β 1 integrins. On the surface of RD-
Figure 1
Characterization of mAb 6B12. A. HT1080 cells were sur-
face labeled with 125I, lysed in the indicated detergents (each
at 1%), and then proteins were immunoprecipitated using
mAb 6B12 (lanes a,b). Also, 125I-labeled Molt4 cells were
lysed in 1% Triton XI 00, and labeled proteins were precipi-
tated using mAb 6B12 (lane c), 4F2 (lane d), or anti-mAb A2-
2E10 (lane e). Proteins were resolved on 10% SDS-PAGE
under reduced conditions. B. Chinese hamster ovary cells
transfected with CD98 cDNA (solid line), with β 1 integrin
cDNA (close dotted line), or mock transfected (dotted line)
were each stained with mAb 6B12. Following FITC-labeled
goat anti-mouse second antibody staining, flow cytometry
was carried out using a FACScan Instrument (Becton Dickin-
son, Mountainview, CA) as previously described [30].BMC Biochemistry 2001, 2:10  http://www.biomedcentral.com/1471-2091/2/10
Figure 2
Selective co-precipitation of integrins with CD98. A. HT1080 cells were surface labeled with 125I, lysed in 1% Brij 58, then
immunoprecipitated with anti-CD98 mAb 6B12. The CD98 immunoprecipitate was then dissociated using 1% Triton X-100
and reprecipitated with mAb to the indicated proteins. Numbers in parentheses above each lane indicate the mean fluores-
cence intensity of each cell surface antigen as determined by flow cytometry analysis. B. HT1080 cells were labeled overnight
with 35S methionine, lysed in 1% Brij 58 then immunoprecipitated with mAb A3-IIF5. Immune complexes were dissociated
using 1% Triton X100 and re-precipitated using anti-CD98 mAb 6B12 or anti-CD81 mAb M38. C. Lysates prepared as in Part
A were analyzed by immunoprecipitation using mAbs A2-2E10, A3-IIF5, A5-PUJ2, and A6-BB respectively (left 4 lanes). Immu-
noprecipitation with mAb 6B12 was followed by elution with 1% Triton X100 and reprecipitation with A2-2E10, A3-IIF5, A5-
PUJ2, and A6-BB mAb respectively (right 4 lanes). D. Cells transfected with wild type α 3 or α 3 integrin lacking a cytoplasmic
tail (X3C0), were surface-labeled with 125I and lysed in 1% Brij 58. Lysates were immunoprecipitated with anti-α 3 mAb A3-IIF5
(left 2 lanes) or first immunoprecipitated with mAb 6B12 then subjected to reprecipitation with mAb A3-IIF5 (right 2 lanes). E.
Cells transfected with wild type α 3 (lane a) or mutant α 3 (W220A or Y218A) were cell surface biotinylated and lysed in 1%
Brij 58. Lysates were immunoprecipitated with anti-α 3 mAb A3-IIF5 (left 3 lanes) or first immunoprecipitated with mAb 4F2
and then subjected to reprecipitation with mAb A3-IIF5 (right 3 lanes).BMC Biochemistry 2001, 2:10  http://www.biomedcentral.com/1471-2091/2/10
A3 cells, CD98 was clustered by incubation with anti-
CD98 mAb 4F2, followed by incubation with rabbit anti-
mouse antibody. Subsequent incubation with anti-α 3
mAb directly conjugated to Alexa-488 revealed that α 3β 1
was highly clustered (Fig. 3C), unless pre-clustering of
CD98 was omitted (Fig. 3A). In contrast, staining with
anti-α 4-Alexa-488 mAb revealed a diffuse pattern of
staining, regardless of CD98 clustering (Fig. 3B, 3D). If
no Alexa-488-conjugated antibodies were added, no
staining was observed (not shown). Immunofluorescent
staining of both α 3β 1 and CD98 showed that they were
distributed similarly on the cell surface of HT1080 and
RD-A3 cells and partially co-localized (not shown).
CD98 mutation and sucrose density gradient localization
The CD98 heavy chain contains two extracellular
cysteines. Each of these cysteines was mutated to serine,
and the effects on β 1 integrin association were evaluated.
Stably expressed human CD98 heavy chain C330S mu-
tant retained association with endogenous murine β 1 in
NIH 3T3 cells, comparable to that seen for wild type
CD98 heavy chain. However, the C109S mutant showed
no detectable β 1 association (Fig. 4A, right panel).
Murine β 1 (Fig. 4A, left panel), and mutant and wild type
forms of CD98 (see legend) were expressed at compara-
ble levels in each of the transfectants. Notably, associa-
tion of CD98 heavy chain with CD98 light chain was
maintained for the C330S mutant, but was lost for the
C109S mutant (not shown), in agreement with previous-
ly published results suggesting that Cysteine 109 is re-
quired for disulfide linkage to the light chain [42]. These
results suggest that the CD98 light chain might be neces-
sary for CD98-integrin association. One possibility is
that the light chain is more proximal to the integrin.
When suitable anti-light chain reagents become availa-
ble, this could be directly tested in covalent crosslinking
experiments. In this regard, we have thus far been unable
to crosslink CD98 heavy chain directly to β 1 integrin, us-
ing either membrane-permeable or membrane-imper-
meable crosslinkers (not shown).
Another possibility is that the CD98 light chain may tar-
get the CD98 heterodimer to the specific membrane do-
main where interactions with β 1 integrins may be
localized. To test the latter hypothesis, we compared the
total β 1 integrin distribution with the distribution of the
fraction of β 1 integrins complexed with CD98 on HT
1080 cells (Fig. 4B). Although β 1 integrins were predom-
inantly present in the dense membrane fraction on a su-
crose gradient, the subset of β 1 integrins complexed with
CD98 was localized to the 'light' membrane fractions.
These fractions typically contain caveolae and 'mem-
brane rafts' thought to be enriched in active signaling
complexes [34,35,43]. The fraction of the β 1 integrins de-
tected in the light membrane fractions represents no
more than 5% of total β 1 integrins (based on the densito-
metric analysis, not shown). Though caveolin is present
in the same fractions as CD98-integrin complexes, it
does not co-immunoprecipitate with CD98 under these
conditions (not shown) and thus is not part of integrin-
CD98 complexes. Similarly, GPI-linked proteins such as
CD 109, TM4SF proteins such as CD81, and other trans-
membrane proteins such as CD147/EMMPRIN can be
found at substantial levels in light membrane fractions
[44,45], and our unpublished results), and these also did
not co-immunoprecipitate with CD98 (Fig. 2A, 2B).
Thus, CD98 association with integrin has another level of
specificity beyond simply co-localizing in light mem-
brane fractions.
Finally, to see whether the CD98 light chain might help
to target the CD98 heavy chain to the light membrane
fractions, we looked at the distribution of the wild type
CD98 and CD98 mutants in the sucrose gradients (Fig.
4C,D). The majority of wild type CD98 heavy chain and
control mutant (C330S) are localized to the light mem-
Figure 3
Integrin clustering induced by CD98 cross-linking. RD A3
cells were grown on coverslips coated with fibronectin (20
µg/ml) for 48 hours. Cells were blocked with 20% goat
serum and in some cases incubated with anti-CD98 mAb 4F2
(10 µg/ml) (C,D). Next, cells were washed, blocked with
20% goat serum and incubated with rabbit anti-mouse Ab (5
µg/ml). Finally, cells were fixed for 15 minutes with 2% para-
formaldehyde, blocked with 20% goat serum and incubated
with anti-α 3 mAb A3X8 PUJ1 (10 µg/ml) (A, C) or anti-α 4
mAb A4-PUJ1 (10 µg/ml) (B, D), each directly coupled with
Alexa-488 (Molecular Probes). Coverslips were mounted
with ProLong AntiFade Kit (Molecular Probes) and immun-
ofluorescence examined using a Zeiss Axioscop equipped
with optics for epifluorescence.BMC Biochemistry 2001, 2:10  http://www.biomedcentral.com/1471-2091/2/10
Figure 4
Correlation between CD98-integrin association and CD98 heavy chain-light chain dimerization. A. NIH 3T3 cells (107 cells/
experiment) expressing wild type human CD98 heavy chain, CD98 heavy chain mutants (C109S or C330S) or control NIH 3T3
cells were lysed in 1% Brij 58 and then proteins were immunoprecipitated using 4F2 mAb. Cell lysates (left 4 lanes) and immu-
noprecipitates (right 4 lanes) were resolved in 8% SDS-PAGE, transferred to nitrocellulose membrane, probed with bioti-
nylated KMI6 mAb (anti-mouse β 1 integrin) followed by incubation with ExtrAvidin-HRP (Sigma) and developed using
Renaissance Chemiluminescence Reagent (NEN Life Science Products, Boston, MA). B. HT1080 cells (107 cells/experiment)
were lysed in sodium carbonate buffer, pH 11 and fractionated in isopycnic discontinuous sucrose gradient as described in
Materials and Methods. Fractions were analyzed by SDS-PAGE electrophoresis followed by Western blot analysis using bioti-
nylated TS2/16 mAb or polyclonal anti-caveolin antibody, or adjusted to pH 7.5 and immunoprecipitated with 4F2 mAb and
then blotted with biotinylated TS2/16 mAb. C. NIH 3T3 cells (107 cells/experiment) expressing wild type human CD98 heavy
chain, or mutant CD98 heavy chains (C109S or C330S) were cell surface biotinylated, lysed in sodium carbonate buffer, pH 11
and fractionated in sucrose gradients as described in Materials and Methods. Fractions were adjusted to pH 7.5 and immuno-
precipitated using 4F2 mAb. Immunoprecipitated proteins were separated in 8% SDS-PAGE under non-reducing conditions and
blotted onto nitrocellulose membrane. Blots were developed using ExtrAvidin-HRP (Sigma) and Renaissance Chemilumines-
cence Reagent (NEN Life Science Products, Boston, MA). For NIH3T3 cells, flow cytometry was used to demonstrate compa-
rable levels of wild type CD98 (MFI = 27), C109S (MFI = 30), and C330S (MFI = 53) expression. Cells were 100% positive, with
homogeneous peaks, well above background staining (MFI = 1). MFI=Mean Fluorescence Intensity. D. Relative distribution of
CD98 wild type and C109S and C330S mutants in light (fractions 3–6) and dense (fractions 9–12) fractions from the Western
blots shown in Fig. 4C. Densitometry was carried out using GeneGenius Bio Imaging System and analysis software, (Syngene,
Frederick, MD). A typical experiment out of three performed is shown.BMC Biochemistry 2001, 2:10  http://www.biomedcentral.com/1471-2091/2/10
brane fraction (55–60%, Fig. 4D), whereas the C109S
mutant is partially shifted to the dense fractions (40% in
the light fraction, 50% in the dense fractions, Fig. 4D).
These results are consistent with the CD98 light chain
targeting the CD98 heavy chain to light membrane frac-
tions. It is perhaps not surprising to observe ~40% of the
C109S heavy chain mutant remaining in the light mem-
brane fraction (Fig. 4C,D), considering that the CD98
heterodimer retains partial association and amino acid
transport function even in the absence of a disulfide link-
age of the subunits [42]. Notably, transformation of
BALB 3T3 cells caused by over-expression of CD98
heavy chain required its association with the light chain,
and a missense mutation in C109 eliminated its trans-
forming activity [10].
The CD98 protein was recently shown to associate spe-
cifically with integrin β  chain cytoplasmic tail fusion pro-
teins [29] in 0.05% Triton X-100 detergent conditions.
One may speculate that the use of 0.05% Triton X-100
may have allowed maintenance of CD98 microdomains,
needed for β 1 interaction. In this regard, in 0.05% Triton
X-100 lysates, many transmembrane proteins remain in
the light membrane fractions of a sucrose gradient
[46,47]. Although the role of the CD98 light chain was
not addressed in the earlier study [29], we assume that it
may have played a key role. Furthermore, CD98 interac-
tion with recombinant β  chain cytoplasmic tail fusion
proteins, in the absence of the α  chain [29], is consistent
with our observation that the α  chain cytoplasmic tail is
not needed for integrin-CD98 association. On the other
hand, we observed CD98 interaction with several β 1 in-
tegrins, but not α 4β 1. Thus for intact integrins in the
context of mammalian cells, the integrin β  chain appar-
ently does contribute to the specificity of CD98 interac-
tion. The α  chain might provide a level of specificity by
changing the conformation of the β  chain and/or by pro-
viding an additional site of interaction with the CD98
light or heavy chains.
Because our integrin-CD98 complex was observed in
light membrane fractions and not in dense sucrose gra-
dient fractions, and because we could not capture the
complex by covalent crosslinking (not shown), the inter-
action may not be direct. Nonetheless, an abundance of
evidence points to the functional relevance of this com-
plex (references above). Furthermore, integrin α Vβ 3-
CD47 complexes have considerable functional relevance,
despite being found only under relatively mild detergent
conditions (e.g. Brij 58) and exclusively in the light mem-
brane fractions of a sucrose gradient [48,49].
Conclusions
In summary, we show a highly specific biochemical link
between intact β 1 integrins and CD98, as demonstrated
by reciprocal co-immunoprecipitation and co-clustering
experiments. Furthermore, CD98 association with β 1 in-
tegrins appears to occur in the context of an ordered lipid
microdomain (as evidenced by co-localization in light
membrane fractions of sucrose density gradients), and
appears to require the light chain of CD98. These results
may help to explain recent reports that CD98 may mod-
ulate integrin ligand binding, adhesion, signaling, T cell
co-stimulation and cell fusion functions.
Materials and Methods
Antibodies, cell lines, cDNA
Monoclonal antibodies used in this study are: 4F2, anti-
CD98 heavy chain [39], A2-2E10, anti-α 2 integrin [32];
A3-IIF5, anti-α 3 integrin [50]; A5-PUJ2, anti-α 5 in-
tegrin [51]; B5G10, anti-α 4 integrin [52]; A4-PUJ1, anti-
α 4 integrin [51]; A6-BB, anti-α 6 integrin [32]; TS2/16,
anti-β 1 integrin; W6/32, anti-HLA class I [53]; C7, anti-
LDL receptor [54]; 5E9, anti-CD71 [55]; IIIC4, anti-CD
109 [32]; 8G6, anti-CD147/EMMPRIN [31]; and KMI6,
anti-mouse  β 1 integrin (Pharmingen, San Diego, CA).
The mAb P3 [56] was used in all immunoprecipitation
and flow cytometry experiments as a negative control.
Human cell lines used in this study were the fibrosarco-
ma cell line HT1080; rhabdomyosarcoma cell line RD
stably transfected with human α 3 integrin (RD A3); lym-
phoblastoid T cell line Molt4, human mammary epitheli-
al cell line MTSV 1–7; erythroleukemia K562 cells and φ
nx-Eco packaging cells. K562 cells expressing integrin
α 4, α 3, or α 3 integrin subunit lacking a cytoplasmic tail
(K562-X3C0) were described elsewhere [30,40]. Also
utilized were K562 cells expressing α 3 D154A, W220A
and Y218A mutants [41], and Chinese hamster ovary
(CHO) cells that express human α 2, α 3, α 5 or β 1 integrin
subunits [30,32]. The cDNA encoding human CD98
heavy chain [57] was provided by Jeffrey Leiden (Univer-
sity of Chicago) in the pUC18 vector. CD98 heavy chain
mutants (C109S and C330S) were made by recombinant
PCR technique [58] with the following primers: C109Ss
– 5'-CGAGCGCCGCGTTCTCGCGAGCTACCGGCG-3';
C109Sas-5'-CGCCGGTAGCTCGCGAGAACGCG-
GCGCTCG-3'; C330Ss – 5'-GGCAATCGCTGGTC-
CAGCTGGAGTTTGTCTCAGGC-3';C330Sas – 5'-
GCCTGAGACAAACTCCAGCTGGACCAGCGATTGCC-
3'. CD98 heavy chain constructs were subcloned into
pLXIZ retroviral vector (Clontech). Transient transfec-
tion of φ  nx-Eco cells and retroviral infection of NIH 3T3
cells was performed as described [59]. Stable NIH 3T3
infectants were selected in growth medium containing 1
mg/ml zeocin.
Immunoprecipitation experiments
For immunoprecipitations, labeled cellular proteins
were extracted with lysis buffer (1% of the indicated de-BMC Biochemistry 2001, 2:10  http://www.biomedcentral.com/1471-2091/2/10
tergent, 20 mM Hepes, pH 7.4, 150 mM NaCl, 2 mM
PMSF, 10 µg/ml leupeptin, 10 µg/ml aprotinin, 2 mM
MgCl2, 0.5 mM CaCl2) for 60 minutes at 4°C. After pre-
incubation with protein A-sepharose 4CL, the cell extract
was incubated with specific mAb directly conjugated to
sepharose 4B for 60 min, washed 3 times with the appro-
priate lysis buffer and eluted with Laemmli sample buff-
er. In some experiments manganese chloride (2 mM)
was added both to cells (10 minutes prior to lysis) and to
the lysis buffer.
For re-immunoprecipitation experiments, associated
proteins were eluted from immune complexes in 1% Tri-
ton X100 in PBS, then pre-incubated with protein A-
sepharose-4CL. Remaining proteins were then re-pre-
cipitated from the eluate using mAb directly conjugated
to sepharose 4B beads for 30 min at 4°C, washed three
times with 1% Triton X100 in PBS, eluted with Laemmli
sample buffer, and resolved on SDS-PAGE.
Detergent-free purification of light membrane fractions
Isopycnic fractionation in sucrose gradients was per-
formed essentially as described [43]. Briefly, cells (one
confluent T162 flask of HT1080 or NIH 3T3 cells ex-
pressing different CD98 constructs) were lysed in 2 ml
500 mM sodium carbonate buffer, pH 11, in the presence
of protease inhibitors and passed through 25 gauge nee-
dle 5 times followed by 6 passages through 27 gauge nee-
dle. The homogenate (1 ml) was adjusted to 45% sucrose
by addition of 1 ml of 90% sucrose in MBS (25 mM MES,
pH6.5, 150 mM NaCl) and placed at the bottom of an ul-
tracentrifuge tube. A 5–35% discontinuous sucrose gra-
dient was formed above (1 ml of 5% sucrose: 2 ml of 35%
sucrose, both in MBS containing 250 mM sodium car-
bonate) and centrifuged at 45 000 rpm for 16–18 hrs in
SW 55 Ti rotor (Beckman Instruments, Palo Alto, CA).
From the top of each gradient 0.4 ml fractions were col-
lected and analyzed by SDS-PAGE electrophoresis, or
adjusted to pH 7.5 (with HCl) and used for immunopre-
cipitation experiments.
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